Umezu T - Search Results

1

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Umezu T, et al. Blood. 2014 Dec 11;124(25):3748-57. doi: 10.1182/blood-2014-05-576116. Epub 2014 Oct 15. Blood. 2014. PMID: 25320245 Free PMC article.

2

Novel Artificial Intelligence Combining Convolutional Neural Network and Support Vector Machine to Predict Colorectal Cancer Prognosis and Mutational Signatures From Hematoxylin and Eosin Images.

Mazaki J, Umezu T, Saito A, Katsumata K, Fujita K, Hashimoto M, Kobayashi M, Udo R, Kasahara K, Kuwabara H, Ishizaki T, Matsubayashi J, Nagao T, Hazama S, Suzuki N, Nagano H, Tanaka T, Tsuchida A, Nagakawa Y, Kuroda M. Mazaki J, et al. Among authors: umezu t. Mod Pathol. 2024 Oct;37(10):100562. doi: 10.1016/j.modpat.2024.100562. Epub 2024 Jul 15. Mod Pathol. 2024. PMID: 39019345 Free article.

3

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.

Ohyashiki JH, Umezu T, Kobayashi C, Hamamura RS, Tanaka M, Kuroda M, Ohyashiki K. Ohyashiki JH, et al. Among authors: umezu t. BMC Res Notes. 2010 Dec 24;3:347. doi: 10.1186/1756-0500-3-347. BMC Res Notes. 2010. PMID: 21182798 Free PMC article.

4

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M, Ohyashiki JH. Ohyashiki K, et al. Among authors: umezu t. PLoS One. 2011 Feb 24;6(2):e16408. doi: 10.1371/journal.pone.0016408. PLoS One. 2011. PMID: 21383985 Free PMC article.

5

Detection method for quantifying global DNA methylation by fluorescence correlation spectroscopy.

Umezu T, Ohyashiki K, Ohyashiki JH. Umezu T, et al. Anal Biochem. 2011 Aug 15;415(2):145-50. doi: 10.1016/j.ab.2011.04.035. Epub 2011 Apr 27. Anal Biochem. 2011. PMID: 21600184

6

Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia.

Kitahara T, Umezu T, Ando K, Kodama A, Ohyashiki JH, Ohyashiki K. Kitahara T, et al. Among authors: umezu t. Hematology. 2011 May;16(3):139-42. doi: 10.1179/102453311X12953015767338. Hematology. 2011. PMID: 21669052 Free article.

7

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.

Ohyashiki JH, Yoneta M, Hisatomi H, Iwabuchi T, Umezu T, Ohyashiki K. Ohyashiki JH, et al. Among authors: umezu t. BMC Med Genet. 2012 Jan 17;13:6. doi: 10.1186/1471-2350-13-6. BMC Med Genet. 2012. PMID: 22251709 Free PMC article.

8

Leukemia cell to endothelial cell communication via exosomal miRNAs.

Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. Umezu T, et al. Oncogene. 2013 May 30;32(22):2747-55. doi: 10.1038/onc.2012.295. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797057

9

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders.

Yoshizawa S, Ohyashiki JH, Ohyashiki M, Umezu T, Suzuki K, Inagaki A, Iida S, Ohyashiki K. Yoshizawa S, et al. Among authors: umezu t. Blood Cancer J. 2012 Jan;2(1):e53. doi: 10.1038/bcj.2011.51. Epub 2012 Jan 20. Blood Cancer J. 2012. PMID: 22829237 Free PMC article.

10

The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients.

Katagiri S, Umezu T, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: umezu t. Br J Haematol. 2013 Jan;160(2):269-71. doi: 10.1111/bjh.12111. Epub 2012 Nov 1. Br J Haematol. 2013. PMID: 23116058 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters